the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Official Title A First-In-Human Phase 1, Dose Escalation, Safety And Pharmacokinetic Study Of PF-06647020 In Adult Patients With Advanced Solid Tumors
Principal Investigator Sharma, Manish
Brief Summary To assess the safety and tolerability at increasing dose levels of PF-06647020 in patients with advanced solid tumors in order to determine the maximum tolerated dose and select the recommended Phase 2 dose.
Gender Both
Ages 18 Years
Enrollment 115
Accepts Healthy Volunteers No
Lead Sponsor PfizerIndustry
Collaborator
Study Design Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Study Phase Phase 1
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Neoplasms
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI